Latitude Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Latitude Advisors's ABBV Position: Q3 2026 in Review
Latitude Advisors reduced its AbbVie (ABBV) stake by 3.9% in Q3 2026, selling an estimated $135K and leaving 12,770 shares worth $3.34M. The position accounts for 1.03% of the portfolio, ranked #15.
Latitude Advisors first reported a position in ABBV in Q3 2021 and has held it in 21 quarters since. The position peaked at $3.35M in Q2 2026. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Latitude Advisors held 12,770 shares of AbbVie worth $3.34M as of Q3 2026.
- Latitude Advisors sold 525 AbbVie shares in Q3 2026, an estimated $135K.
- AbbVie made up 1.03% of Latitude Advisors's portfolio in Q3 2026, its #15 holding.
- Latitude Advisors first reported a position in AbbVie in Q3 2021 and has held it in 21 quarters since.
- Latitude Advisors's AbbVie position peaked at $3.35M in Q2 2026.
- 1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Latitude Advisors's 13F filing for Q3 2026, filed 27 Oct 2026.